Systematic Financial reports 6.05% AngioDynamics (ANGO) stake

Rhea-AI Filing Summary

Systematic Financial Management filed a Schedule 13G reporting a passive ownership stake in AngioDynamics Inc. common stock. The firm beneficially owns 2,508,295 shares, representing 6.05% of the outstanding common stock, with sole voting power over 1,478,345 shares and sole dispositive power over all 2,508,295 shares.

The filing states that the shares were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of AngioDynamics. The reported holdings relate to AngioDynamics common stock with CUSIP 03475V101.

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

ANGIODYNAMICS INC

(Name of Issuer)

Common Stock

(Title of Class of Securities)

03475V101

(CUSIP Number)

12/31/2025

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

SCHEDULE 13G

CUSIP No. 03475V101

1

Names of Reporting Persons

SYSTEMATIC FINANCIAL MANAGEMENT LP

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

UNITED STATES

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 1,478,345.00
6	Shared Voting Power 0.00
7	Sole Dispositive Power 2,508,295.00
8	Shared Dispositive Power 0.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

2,508,295.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

6.1 %

12

Type of Reporting Person (See Instructions)

IA

SCHEDULE 13G

Item 1.
(a)	Name of issuer: ANGIODYNAMICS INC
(b)	Address of issuer's principal executive offices: 14 PLAZA DRIVE, LATHAM, NEW YORK, 12110
Item 2.
(a)	Name of person filing: Michele Egeberg, Managing Director, Compliance
(b)	Address or principal business office or, if none, residence: 300 Frank W. Burr Blvd., Glenpointe East, 7th Floor, Teaneck, NJ 07666
(c)	Citizenship: U.S.A.
(d)	Title of class of securities: Common Stock
(e)	CUSIP No.: 03475V101
Item 3.	If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)	An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)	An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)	A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:
(k)	Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.	Ownership
(a)	Amount beneficially owned: 2,508,295
(b)	Percent of class: 6.05%
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: 1,478,345
	(ii) Shared power to vote or to direct the vote: 0
	(iii) Sole power to dispose or to direct the disposition of: 2,508,295
	(iv) Shared power to dispose or to direct the disposition of: 0
Item 5.	Ownership of 5 Percent or Less of a Class.
	Not Applicable
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	Not Applicable
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	Not Applicable
Item 8.	Identification and Classification of Members of the Group.
	Not Applicable
Item 9.	Notice of Dissolution of Group.
	Not Applicable

Item 10.

Certifications:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

SYSTEMATIC FINANCIAL MANAGEMENT LP

Signature:	Michele Egeberg
Name/Title:	Managing Director, Compliance
Date:	02/10/2026

FAQ

What percentage of AngioDynamics (ANGO) does Systematic Financial Management own?

Systematic Financial Management reports owning 6.05% of AngioDynamics common stock. This ownership is based on 2,508,295 beneficially owned shares, giving the firm a passive but reportable stake under Schedule 13G rules for holdings above five percent.

How many AngioDynamics shares does Systematic Financial Management report on its Schedule 13G?

Systematic Financial Management reports beneficial ownership of 2,508,295 AngioDynamics common shares. It has sole voting power over 1,478,345 of those shares and sole dispositive power over the full 2,508,295-share position, with no shared voting or dispositive authority disclosed.

Is Systematic Financial Management’s stake in AngioDynamics considered passive or activist?

The stake is described as passive. The certification states the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of AngioDynamics, consistent with a Schedule 13G rather than an activist Schedule 13D.

What voting power does Systematic Financial Management have over AngioDynamics shares?

Systematic Financial Management reports sole voting power over 1,478,345 AngioDynamics common shares. It discloses no shared voting power, indicating that only this portion of the 2,508,295 beneficially owned shares can be voted directly at its discretion under the filing.

What is the CUSIP and security class reported for AngioDynamics in this Schedule 13G?

The filing covers AngioDynamics Inc. Common Stock with CUSIP 03475V101. This identifies the specific class of securities for which Systematic Financial Management reports beneficial ownership and ensures clarity about the exact security referenced in the Schedule 13G.